News

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...
Opinion
Zacks Investment Research on MSN14hOpinion
Bull of the Day: Hims & Hers Health (HIMS)
Hims & Hers Health (HIMS) has emerged as a disruptive force in telehealth, leveraging technology and personalization to address highly-personal health conditions while achieving scalable profitability ...
Highlights Semaglutide medications like Ozempic may cause facial changes. You can take steps to help minimize or prevent ...
Millions of people compulsively pick their skin or pull their hair. Social media is helping some of them to recover.
A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...